The #1 Medical Tourism Platform since 2014
Patient Safety
Patient Safety

Okkes Baz

Ophtalmologist

11 years of experience
Dr. Okkes Baz is a well-established ophthalmologist with expertise in vitreoretinal surgery, cataract surgery, and medical retina. He is proficient in procedures such as vitrectomy, laser trabeculoplasty, and LASIK eye surgery among others. Dr. Baz is a member of the American Academy of Ophthalmology and the Turkish Ophthalmology Association, and has a number of relevant publications to his name.

Location

Dr. Okkes Baz offers a wide range of operations including vitrectomy, laser trabeculoplasty, LASIK eye surgery, IOLs implantation, retina transplantation, Botox injections, strabismus surgery, laser iridotomy, trabeculotomy, and cataract surgery with multifocal lens implant.

Education

  • Medical Education from Istanbul Medical Faculty (2001-2007)
  • Ophthalmology Specialization at Prof. dr. Reşat Belger Beyoğlu Eye Training and Research Hospital (2008-2012)
  • Faculty member at Esenyurt University (2018 - Present)

Professional Memberships

  • American Academy of Ophthalmology (AAO)
  • Türk Oftalmoloji Derneği (TOD)

Publications

  • Relationship between corneal biomechanical properties and optic nerve head parameters in healthy subjects (Glo-Kat 2011)
  • Comparison of suture and fibrin glue methods in conjunctival autograft pterygium surgery (MN Ophthalmology)
  • Effectiveness of laser suture lysis in early high intraocular pressure after trabeculectomy (TJO 2013)
  • Approach to encapsulated blebs after filtering surgery (TJO 2013)
  • Evaluation of optical coherence tomography image quality and macular thickness in patients with posterior capsule opacification (Ret-Vit 2011)
  • Efficacy of intravitreal bevacizumab in the treatment of proliferative idiopathic juxtafoveal telangiectasia (TJO 2017)
  • Short-term efficacy of subthreshold micropulse yellow laser in chronic central serous chorioretinopathy (Journal of Retina-Vitreous 2017)
  • Combination of photodynamic therapy and bevacizumab for polypoidal choroidal vasculopathy refractory to intravitreal ranibizumab (Beyoglu Eye J 2016)
  • Efficacy of intravitreal bevacizumab in vitreous hemorrhage of diabetic subjects (Turk J Ophthalmol 2016)